Why Humana Inc. (HUM) stock moved
Humana Inc. (HUM) shares climbed 11.3% to $431.03 as of October 9, 2026, a sharp gain from the prior close of $387.12. BestStocks flagged the session as a major change for HUM. Below, we break down what changed for HUM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HUM climbed 11.3% to $431.03
Humana surged 11.84% after the Centers for Medicare & Medicaid Services released its final 2027 Medicare Advantage Star Ratings, showing 95% of HUM's Medicare Advantage members will be in 4-star or higher plans—a dramatic jump from 20% in 2026 (Reuters, Yahoo Finance). The company's flagship H5216 contract recovered to 4 stars from 3.5 stars, restoring eligibility for quality bonus payments affecting ~2.4 million members. Analyst Baird upgraded HUM from Neutral to Outperform and raised its price target to $596. Humana earnings on 2026-11-04 (consensus EPS estimate −$0.90, date not yet confirmed)—likely to update 2027 revenue and earnings guidance based on star-rating monetization.
What it means for Humana Inc. investors
For Humana Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Strong 11.3% price move with conviction; Volume 3.8x average — institutional conviction. Weighing against that: Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60; Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16. Wall Street's consensus price target sits at $460.74, implying +6.9% upside from $431.03. Over the past 90 days analysts logged 6 upgrades and 1 downgrade. BestStocks rates the overall signal quality medium (75/100). With earnings roughly 28 days out, the next report is the most likely near-term test of the move.
HUM price reaction
HUM last traded at $431.03, up $43.91 (+11.34%) from the previous close of $387.12. The session traded on 3.8× average volume (extreme), so the move carried above-average conviction.
Bullish and bearish analyst opinions on Humana Inc. (HUM)
The consensus analyst price target on Humana Inc. (HUM) is $460.74, 6.9% above the recent $431.03. Over the past 90 days analysts logged 6 upgrades, 9 maintains, and 1 downgrade. Here is how the bullish and bearish cases on HUM line up.
The bullish case
- Wall Street's consensus price target of $460.74 implies +6.9% upside from $431.03.
- The Street's most bullish target is $596.00 (+38.3%).
- 6 analyst upgrades in the past 90 days, most recently Baird to Outperform (2026-10-09).
- Strong 11.3% price move with conviction.
- Volume 3.8x average — institutional conviction.
The bearish case
- The most bearish analyst target is $300.00 (-30.4%).
- 1 analyst downgrade in the past 90 days, most recently Raymond James to Market Perform (2026-07-30).
- Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60.
- Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 9, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HUM
In-depth HUM event analyses
Frequently asked questions about HUM
Why did Humana Inc. (HUM) stock move?
HUM climbed 11.3% to $431.03. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did HUM stock rise?
HUM gained 11.34% ($43.91) versus the prior close of $387.12, last trading at $431.03 on 3.8× average volume.
When is Humana Inc.'s next earnings date?
HUM's next earnings report is estimated for 2026-11-06 — about 28 days away.
What is the analyst price target for HUM?
The consensus analyst price target for HUM is $460.74, about 6.9% above the current $431.03. Over the past 90 days, analysts recorded 6 upgrades, 9 maintains, and 1 downgrade.
How BestStocks tracks HUM
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HUM-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for HUM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 9, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.